Predicting factors of hypoglycaemia in elderly type 2 diabetes patients: Contributions of the GERODIAB study

Diabetes and Metabolism

Volumn 41, Issue 4, 2015, Pages 301-303

  Bordier, L ^a   Buysschaert, M ^b   Bauduceau, B ^a   Doucet, J ^c   Verny, C ^d   Lassmann Vague, V ^e   Le Floch, J P ^f  

^a SERVICE D ENDOCRINOLOGIE   (France)

^b CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^c ROUEN UNIVERSITY HOSPITAL   (France)

^d BICÊTRE HOSPITAL   (France)

^e Medical Center Paul Paret   (France)

^f Villecresnes Medical Hospital   (France)

Author keywords

Ageing; Geriatric scales; GERODIAB; Hypoglycaemia; Type 2 diabetes

Indexed keywords

DIPEPTIDYL PEPTIDASE IV INHIBITOR; GLUCAGON LIKE PEPTIDE 1; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METFORMIN; SULFONYLUREA; ANTIDIABETIC AGENT;

AGED; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; GERIATRIC DEPRESSION SCALE; GERIATRIC PATIENT; HUMAN; HYPOGLYCEMIA; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MORBIDITY; MORTALITY; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PROGNOSIS; RETINOPATHY; COMPLICATION; DEPRESSION; DIABETES MELLITUS, TYPE 2; GERIATRIC ASSESSMENT; MULTICENTER STUDY (TOPIC); RISK FACTOR; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS; VERY ELDERLY;

AGED; AGED, 80 AND OVER; DEPRESSION; DIABETES MELLITUS, TYPE 2; GERIATRIC ASSESSMENT; HUMANS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; MORBIDITY; MULTICENTER STUDIES AS TOPIC; PROGNOSIS; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS;

EID: 84941874077     PISSN: 12623636     EISSN: 18781780     Source Type: Journal    
DOI: 10.1016/j.diabet.2015.03.001     Document Type: Article

References (9)

1. Doucet J., Le Floch J.P., Bauduceau B., Verny C., SFD/SFGG Intergroup GERODIAB: glycaemic control and 5-year morbidity/mortality of type 2 diabetic patients aged 70 years and older: 1. Description of the population at inclusion. Diabetes Metab 2012, 38:523-530.
2. Tschöpe D., Bramlage P., Binz C., Krekler M., Deeg E., Gitt A.K. Incidence and predictors of hypoglycaemia in type 2 diabetes - an analysis of the prospective DiaRegis registry. BMC Endocr Disord 2012, 12:23.
3. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998, 352:837-853. UK Prospective Diabetes Study (UKPDS) Group.
4. Alvarez Guisasola F., Tofé Povedano S., Krishnarajah G., Lyu R., Mavros P., Yin D. Hypoglycaemic symptoms, treatment satisfaction, adherence and their associations with glycaemic goal in patients with type 2 diabetes mellitus: findings from the Real-Life Effectiveness and Care Patterns of Diabetes Management (RECAP-DM) Study. Obes Metab 2008, 10(Suppl. 1):25-32.
5. Nicolucci A., Pintaudi B., Rossi M.C., Messina R., Dotta F., Frontoni S., et al. The social burden of hypoglycaemia in the elderly. Acta Diabetol 2015, [Epub ahead of print]. 10.1007/s00592-015-0717-0.
6. Yaffe K., Falvey C.M., Hamilton N., Simonsick E.M., Strotmeyer E.S., Shorr R.I., et al. Association between hypoglycaemia and dementia in a biracial cohort of older adults with diabetes mellitus. JAMA Intern Med 2013, 22:1300-1306.
7. Khan M.I., Barlow R.B., Weinstock R.S. Acute hypoglycaemia decreases central retinal function in the human eye. Vision Res 2011, 51:1623-1626.
8. Kilpatrick E.S., Rigby A.S., Atkin S.L., Frier B.M. Does severe hypoglycaemia influence microvascular complications in type 1 diabetes? An analysis of the Diabetes Control and Complications Trial database. Diabet Med 2012, 29:1195-1198.
9. Emery M., Schorderet D.F., Roduit R. Acute hypoglycaemia induces retinal cell death in mouse. PLoS One 2011, 6(6):e21586. 10.1371/journal.pone.0021586.